Portfolio Holdings Detail for ISIN IE00B3VWM098

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE

Holdings detail for AVNS

Show aggregate AVNS holdings

News associated with AVNS

Avanos Medical Acquires Nexus Medical To Expand Specialty Nutrition Systems Business

(RTTNews) - Avanos Medical, Inc. (AVNS), a medical technology company, on Monday announced that it has acquired Nexus Medical, LLC, a privately held medical device company based in Lenexa, Kansas. - 2025-09-15 08:32:41

AVANOS MEDICAL, INC. (NYSE:AVNS) Short Interest Up 25.8% in July

AVANOS MEDICAL, INC. (NYSE:AVNS – Get Free Report) was the target of a large growth in short interest during the month of July. As of July 31st, there was short interest totaling 1,900,000 shares, agrowthof25.8% from the July 15th total of 1,510,000 shares. Based on an average daily volume of 491,900 shares, the short-interest ratio […] - 2025-08-22 02:00:50

Friday 8/15 Insider Buying Report: PSX, AVNS

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today - 2025-08-15 14:46:40

Avanos Medical (NYSE:AVNS) Hits New 1-Year Low on Disappointing Earnings

Avanos Medical, Inc. (NYSE:AVNS – Get Free Report) hit a new 52-week low on Wednesday following a dissappointing earnings announcement. The company traded as low as $9.30 and last traded at $9.98, with a volume of 1634728 shares changing hands. The stock had previously closed at $11.25. The company reported $0.17 earnings per share for […] - 2025-08-07 02:26:50

New Strong Sell Stocks for July 15th

DDD, AVNS and BABA have been added to the Zacks Rank #5 (Strong Sell) List on July 15, 2025. - 2025-07-15 06:25:00

Avanos Medical, Inc. (NYSE:AVNS) Shares Purchased by Azzad Asset Management Inc. ADV

Azzad Asset Management Inc. ADV boosted its stake in Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 3.5% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 41,039 shares of the company’s stock after acquiring an additional 1,404 shares during the period. Azzad Asset […] - 2025-06-16 05:40:51

Two Sigma Investments LP Has $1.16 Million Position in Avanos Medical, Inc. (NYSE:AVNS)

Two Sigma Investments LP grew its stake in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 20.6% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 72,701 shares of the company’s stock after buying an additional 12,422 shares during the period. Two Sigma Investments LP’s holdings […] - 2025-06-05 04:44:55

ProShare Advisors LLC Has $218,000 Holdings in Avanos Medical, Inc. (NYSE:AVNS)

ProShare Advisors LLC grew its position in Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 44.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,693 shares of the company’s stock after purchasing an additional 4,210 shares during the period. ProShare […] - 2025-06-01 05:50:47

Avanos Medical, Inc. (NYSE:AVNS) Shares Acquired by State of Wyoming

State of Wyoming raised its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 132.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,137 shares of the company’s stock after purchasing an additional 2,923 shares during the […] - 2025-05-28 05:15:07

Avanos Medical, Inc. (NYSE:AVNS) Shares Purchased by Gotham Asset Management LLC

Gotham Asset Management LLC increased its stake in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 5.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,234 shares of the company’s stock after acquiring an additional 1,425 shares during the quarter. […] - 2025-05-20 05:06:50

14,609 Shares in Avanos Medical, Inc. (NYSE:AVNS) Acquired by Balyasny Asset Management L.P.

Balyasny Asset Management L.P. purchased a new position in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 14,609 shares of the company’s stock, valued at approximately $233,000. A number of other institutional investors have also added to […] - 2025-05-18 05:45:18

Price T Rowe Associates Inc. MD Reduces Position in Avanos Medical, Inc. (NYSE:AVNS)

Price T Rowe Associates Inc. MD decreased its holdings in Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 31.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 44,908 shares of the company’s stock after selling 20,317 shares during the quarter. Price T Rowe […] - 2025-05-12 05:18:59

Avanos Medical, Inc. (NYSE:AVNS) Shares Acquired by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC lifted its position in Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 493.3% in the fourth quarter, Holdings Channel reports. The firm owned 8,075 shares of the company’s stock after acquiring an additional 6,714 shares during the period. Tower Research Capital LLC TRC’s holdings in Avanos Medical were worth $129,000 […] - 2025-05-08 05:12:45

Avanos Medical (NYSE:AVNS) Shares Up 6.5% Following Better-Than-Expected Earnings

Avanos Medical, Inc. (NYSE:AVNS – Get Free Report)’s share price traded up 6.5% during trading on Tuesday following a stronger than expected earnings report. The company traded as high as $13.20 and last traded at $12.99. 85,289 shares were traded during trading, a decline of 75% from the average session volume of 339,818 shares. The […] - 2025-05-07 03:05:14

Avanos Medical, Inc. (NYSE:AVNS) Shares Sold by Barclays PLC

Barclays PLC decreased its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 16.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 80,201 shares of the company’s stock after selling 15,993 shares during the quarter. Barclays PLC’s holdings in Avanos Medical […] - 2025-05-05 04:46:49

Marshall Wace LLP Makes New Investment in Avanos Medical, Inc. (NYSE:AVNS)

Marshall Wace LLP bought a new position in Avanos Medical, Inc. (NYSE:AVNS – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 64,765 shares of the company’s stock, valued at approximately $1,031,000. Several other institutional investors and hedge […] - 2025-04-30 05:04:55

Envestnet Asset Management Inc. Purchases 17,504 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Envestnet Asset Management Inc. increased its position in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 15.8% during the 4th quarter, Holdings Channel reports. The fund owned 128,567 shares of the company’s stock after buying an additional 17,504 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Avanos Medical were worth $2,047,000 […] - 2025-04-28 05:08:52

Federated Hermes Inc. Sells 42,916 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Federated Hermes Inc. reduced its position in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 33.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 83,766 shares of the company’s stock after selling 42,916 shares during the quarter. Federated Hermes Inc. owned about […] - 2025-04-15 05:34:57

American Century Companies Inc. Increases Holdings in Avanos Medical, Inc. (NYSE:AVNS)

American Century Companies Inc. increased its stake in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 9.6% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 105,112 shares of the company’s stock after purchasing an additional 9,249 shares during the period. American Century Companies Inc.’s […] - 2025-04-10 04:26:52

Illinois Municipal Retirement Fund Purchases 748 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Illinois Municipal Retirement Fund lifted its position in shares of Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 25,236 shares of the company’s stock after acquiring an additional 748 shares during […] - 2025-03-05 08:01:03

Short Interest in Avanos Medical, Inc. (NYSE:AVNS) Drops By 5.2%

Avanos Medical, Inc. (NYSE:AVNS – Get Free Report) saw a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 632,000 shares, a decrease of 5.2% from the January 15th total of 666,900 shares. Based on an average trading volume of 444,200 shares, the short-interest ratio […] - 2025-02-19 07:05:46

Trust Point Inc. Decreases Stock Holdings in Avanos Medical, Inc. (NYSE:AVNS)

Trust Point Inc. lessened its holdings in Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 52.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 13,022 shares of the company’s stock after selling 14,317 shares during the quarter. Trust Point Inc.’s holdings in Avanos Medical were worth $207,000 at the end of the most recent […] - 2025-02-07 07:27:28

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc AVNS holdings

Date	Number of AVNS Shares Held	Base Market Value of AVNS Shares	Local Market Value of AVNS Shares	Change in AVNS Shares Held	Change in AVNS Base Value	Current Price per AVNS Share Held	Previous Price per AVNS Share Held
2025-09-26 (Friday)	4,824	USD 56,778	USD 56,778
2025-09-25 (Thursday)	4,824	USD 55,717	USD 55,717	0	USD -2,653	USD 11.55	USD 12.0999
2025-09-24 (Wednesday)	4,824	USD 58,370	USD 58,370
2025-09-17 (Wednesday)	4,794	USD 56,857	USD 56,857	0	USD -144	USD 11.86	USD 11.8901
2025-09-16 (Tuesday)	4,794	USD 57,001	USD 57,001
2025-09-12 (Friday)	4,764	USD 58,216	USD 58,216
2025-09-11 (Thursday)	4,764	USD 59,121	USD 59,121

Share Trades of AVNS by Blackrock for IE00B3VWM098

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-08-21	SELL	-15			11.160*		14.81 Profit of 222 on sale
2025-07-31	BUY	45			11.170*		14.86
2025-06-30	SELL	-30			12.240*		15.23 Profit of 457 on sale
2025-06-25	SELL	-15			12.270*		15.29 Profit of 229 on sale
2025-06-20	SELL	-30			12.140*		15.36 Profit of 461 on sale
2025-05-23	BUY	15			12.310*		15.85
2025-05-19	SELL	-15			12.990*		15.96 Profit of 239 on sale
2025-05-15	SELL	-45			12.750*		16.01 Profit of 720 on sale
2025-05-12	SELL	-15			13.100*		16.10 Profit of 241 on sale
2025-05-09	SELL	-15			12.650*		16.13 Profit of 242 on sale
2025-04-30	SELL	-15			12.550*		16.37 Profit of 246 on sale
2025-04-24	SELL	-30			12.530*		16.53 Profit of 496 on sale
2025-04-17	SELL	-15			12.430*		16.75 Profit of 251 on sale
2025-04-15	SELL	-45			12.030*		16.85 Profit of 758 on sale
2025-04-14	SELL	-45			12.410*		16.90 Profit of 760 on sale
2025-04-09	SELL	-60			13.180*		17.04 Profit of 1,022 on sale
2025-04-07	SELL	-105			12.930*		17.14 Profit of 1,800 on sale
2025-04-04	SELL	-150			13.420*		17.18 Profit of 2,577 on sale
2025-03-31	BUY	15			14.330*		17.28
2025-03-19	SELL	-30			14.820*		17.59 Profit of 528 on sale
2025-03-14	SELL	-90			14.460*		17.72 Profit of 1,594 on sale
2025-03-13	SELL	-30			14.470*		17.76 Profit of 533 on sale
2025-03-12	SELL	-510			14.600*		17.81 Profit of 9,081 on sale
2025-03-07	SELL	-30			15.240*		17.93 Profit of 538 on sale
2025-03-06	SELL	-45			15.230*		17.97 Profit of 809 on sale
2025-03-03	SELL	-15			15.130*		18.11 Profit of 272 on sale
2025-02-28	SELL	-90			15.050*		18.16 Profit of 1,634 on sale
2025-02-26	SELL	-15			15.620*		18.25 Profit of 274 on sale
2025-02-25	SELL	-45			15.560*		18.30 Profit of 823 on sale
2025-02-18	BUY	75			15.530*		18.61
2025-02-13	BUY	15			16.630*		18.73
2025-02-12	BUY	15			16.480*		18.77
2025-02-11	BUY	45			16.680*		18.82
2025-02-06	BUY	135			16.990*		18.96
2025-01-27	BUY	15			16.950*		19.35
2024-12-30	BUY	75			15.580*		19.78
2024-12-06	BUY	60			18.470*		19.91
2024-12-05	BUY	15			18.890*		19.94
2024-12-04	BUY	75			19.100*		19.97
2024-11-29	BUY	75			19.160*		20.06
2024-11-27	BUY	60			19.140*		20.14
2024-11-26	BUY	15			19.160*		20.18
2024-11-21	BUY	75			18.020*		20.42
2024-11-20	BUY	45			17.870*		20.56
2024-11-18	BUY	180			18.120*		20.89
2024-11-12	BUY	120			19.900*		20.95
2024-11-08	BUY	75			20.410*		20.99
2024-11-07	BUY	225			20.430*		21.04
2024-11-06	BUY	30			20.950*		21.04
2024-10-31	BUY	15			18.680*		22.02

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AVNS

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer